Lux Venture Partners Iv, Llc - Net Worth and Insider Trading
Lux Venture Partners Iv, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lux Venture Partners Iv, Llc owns 5 companies in total, including Recursion Pharmaceuticals Inc (RXRX) , Aeva Technologies Inc (AEVA) , and Science 37 Holdings Inc (SNCE) among others .
Click here to see the complete history of Lux Venture Partners Iv, Llc’s form 4 insider trades.
Insider Ownership Summary of Lux Venture Partners Iv, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2021-12-07 | other: Former 10% Owner |
| AEVA | Aeva Technologies Inc | 2021-03-12 | 10 percent owner |
| SNCE | Science 37 Holdings Inc | 2021-10-06 | 10 percent owner |
 | | 2021-06-04 | 10 percent owner |
| | 2021-06-04 | 10 percent owner |
Lux Venture Partners Iv, Llc Trading Performance
Lux Venture Partners Iv, Llc Ownership Network
Ownership Network List of Lux Venture Partners Iv, Llc
Ownership Network Relation of Lux Venture Partners Iv, Llc
Lux Venture Partners Iv, Llc Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Lux Venture Partners Iv, Llc is the other: Former 10% Owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include President and COO Tina Marriott Larson , Chief Financial Officer Michael Secora , and director & 10 percent owner & Chief Executive Officer Christopher Gibson .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Lux Venture Partners Iv, Llc made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 496,133 shares made by Blake Borgeson , a net sale of 1,209,278 shares made by Christopher Gibson , and a net sale of 94,000 shares made by Tina Marriott Larson .
In summary, during the past 3 months, insiders sold 256,682 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 256,682 shares. During the past 18 months, 2,974,541 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,974,541 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Lux Venture Partners Iv, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Lux Venture Partners Iv, Llc. You might contact Lux Venture Partners Iv, Llc via mailing address: 920 Broadway, 11th Floor, New York Ny 10010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
